Tag: Daniel Koller
Biotech stocks are interesting for investors
Blood cancer cells and immunoglobins The biotech company Amgen develops therapies against cancer. In late August, Amgen’s stock rose 7 percent after it acquired another biotech company. (Photo: obs) Cologne…